Table 5.
Secondary outcomes of changes in medications and preventive and hypertension screening tests.
| Secondary outcomes | Total (n=500) |
Intervention (n=282) |
Control (n=218) |
P valuea | |
| Medications, mean (SD) |
|
|
|
|
|
|
|
Total number of medications at baseline | 1.61 (1.0) | 1.51 (1.0) | 1.73 (1.0) | .16 |
|
|
Total number of medications at follow-up | 1.39 (1.1) | 1.34 (1.1) | 1.45 (1.1) | .64 |
|
|
Change in number of medications | –0.22 (0.93) | –0.17 (0.92) | -0.28 (0.93) | .64 |
| Preventive services, n (%) |
|
|
|
|
|
|
|
Tetanus vaccine within 1 year | 45 (9.0) | 15 (5.3) | 30 (13.8) | .02 |
|
|
Pneumonia vaccine within 1 year | 41 (8.2) | 16 (5.7) | 25 (11.5) | .02 |
|
|
Influenza vaccine within 1 year | 280 (56.0) | 152 (53.9) | 128 (58.7) | .81 |
|
|
Colonoscopy within 1 year | 37 (7.4) | 22 (7.8) | 15 (6.9) | .72 |
| Hypertension screening tests, n (%) |
|
|
|
|
|
|
|
Serum creatinine tested within 1 year | 367 (73.4) | 211 (74.8) | 156 (71.6) | .56 |
|
|
Urine protein tested within 1 year | 144 (28.8) | 86 (30.5) | 58 (26.6) | .26 |
|
|
Serum potassium tested within 1 year | 362 (72.4) | 209 (74.1) | 153 (70.2) | .31 |
a P value from 2-sample t test for continuous outcomes and Pearson chi-square test for categorical outcomes.